EDMONTON, Alberta, Oct. 16 /PRNewswire-FirstCall/ -- Medical Services International Inc (OTC:MSITF) is pleased to announce that it has acquired an additional distributor in South Africa. The new distributor has begun an aggressive marketing plan related to the VScan test kits starting with the VScan HIV test kit. For the first time, the South African government is asking for tenders related to Rapid test kits for HIV. The VScan HIV rapid test kit is ideally suited to the South African environment. The HIV test kit must be able to be used in remote areas with limited medical facilities and no refrigeration. The VScan rapid test kit for detection of HIV is ideally suited to be used in this environment. It is easy to use, designed specifically to use whole blood in adverse environments while maintaining an accuracy greater than 99%. It is the only kit currently available that measures the antibody IgM in whole blood in the field. IgM is the first antibody to be detected once infection of the HIV virus has occurred. Prior testing completed by regulatory bodies in South Africa show that the test kits for HIV have an accuracy greater than 99%. The new distributor anticipates that they will require in excess of 2.5 million VScan test kits over the next 12 months in order to fill the current demand for a rapid screening test for HIV. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use test for the screening of HIV1&2, Hepatitis B7C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF." For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc at +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright